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Males and females have a variety of sexually dimor-
phic traits, most of which result from hormonal dif-
ferences. However, differences between male and
female embryos initiate very early in development,
before hormonal influence begins, suggesting the
presence of genetically driven sexual dimorphisms.
By comparing the gene expression profiles of male
and X-inactivated female human pluripotent stem
cells, we detected Y-chromosome-driven effects.
We discovered that the sex-determining gene SRY
is expressed in human male pluripotent stem cells
and is induced by reprogramming. In addition, we de-
tected more than 200 differentially expressed auto-
somal genes in male and female embryonic stem
cells. Some of these genes are involved in steroid
metabolism pathways and lead to sex-dependent
differentiation in response to the estrogen precursor
estrone. Thus, we propose that the presence of the
Y chromosome and specifically SRY may drive sex-
specific differences in the growth and differentiation
of pluripotent stem cells.INTRODUCTION
Sex determination in mammals is a two-step process governed
by sex chromosome content and hormone production. Initially,
sex chromosome content drives the differentiation of bipotential
gonadal ridges into either testis or ovary (Camerino et al., 2006).
Subsequently, sex hormones produced by the gonads drive the
establishment of a range of anatomical and physiological charac-
teristics known as phenotypic sex (Camerino et al., 2006). In hu-
mans, gonadal development occurs between the fourth and fifth
week after conception, suggesting that earlier processes such as
gastrulation, neural tube closure, and somite development are
mainly influenced by genetic content. Indeed, there is evidence
of sex-dimorphic traits occurring before hormonal secretion
(Arnold, 2012). For example, male and female dopaminergic
neurons derived before hormone production show different
morphologies and functions in culture (Engele et al., 1989).
Furthermore, sex-specific differences in the number of tyrosine
hydroxylase (TH)-containing neurons were detected in themidbrain and diencephalon of embryonic day 14 (E14) rats
(Carruth et al., 2002). In addition, recent work also revealed a
difference in H3K27me3 between UTX null male and female em-
bryonic stem cells (ESCs) (Welstead et al., 2012), indicating a
distinct role for the UTX/UTY genes. Thus, genetically driven di-
morphismsmay play an important role during early development.
Since themain genetic difference between the sexes following
X inactivation in females is the presence of the Y chromosome,
this chromosome should play an important role in any genetically
driven dimorphic trait. The sex chromosomes are thought to
have evolved by the gain of sex-specific beneficial genes on a
set of ancestral autosomes (Graves et al., 2006). Consequently,
Y-linked genes are classified based on their similarity to the bet-
ter-preserved X-linked genes (Tilford et al., 2001) and as unique,
Y-specific genes thought to be crucial for the male phenotype
(Skaletsky et al., 2003). Indeed, male development was found
to be dependent on the presence of the sex-determining region
Y (SRY) gene (Sinclair et al., 1990), as well as on a set of male-
specific genes believed to be expressed only in the gonads
(Vogt et al., 1997). In human pluripotent stem cell lines (either hu-
man ESCs or induced pluripotent stem cells [iPSCs]), X inactiva-
tion frequently occurs in the undifferentiated state, resulting in an
identical content of X chromosomes inmales and females (Bruck
and Benvenisty, 2011; Mekhoubad et al., 2012). The exact timing
of X activation or inactivation following reprogramming and ESC
derivation is still being debated (Marchetto et al., 2010; Mekhou-
bad et al., 2012; Nazor et al., 2012; Tomoda et al., 2012). How-
ever, the existence of X inactivation in female ESCs makes
them a good model for the investigation of genetically driven
sex-dimorphic traits during early development. In this study,
we set out to discover genetically driven differences between
males and females during early development. To this end, we
compared the global gene expression of X inactive human
pluripotent female cell lines and male cell lines, and investigated
possible effects resulting from the Y chromosome.We found that
the sex-determining gene SRY is expressed in male pluripotent
cells and that the expression of SRY may affect autosomal
gene expression, resulting in differences in steroid metabolism
and potentially in differentiation between the sexes.RESULTS
Y Chromosome Expression
In order to detect differentially expressed genes in human plurip-
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data comprised of female and male ESC and iPSC lines (Table
S1) published in the GEO database (Edgar et al., 2002). All of
the cell lines were normal diploid cells as determined by karyo-
type analysis and gene-expression-based chromosomal integ-
rity analysis (Mayshar et al., 2010). To faithfully compare male
and female cell lines, we examined the gene expression of all fe-
male lines for complete inactivation of one X chromosome (Bruck
and Benvenisty, 2011). Recent findings suggest that XIST
expression may be an important indicator for X inactivation sta-
bility (Mekhoubad et al., 2012; Nazor et al., 2012); however, mul-
tiple studies have shown that XIST expression is not required
following complete inactivation of the X chromosome (Anguera
et al., 2012; Silva et al., 2008). To ensure complete X inactivation,
we chose all of the female samples based on the expression
levels of genes on the entire X chromosome (Figure S1A).
Thus, the data set was composed of 23 female samples, repre-
senting 10 independent female lines from 12 independent labo-
ratories, and 81male samples representing 51 independentmale
lines from 21 laboratories. We initially investigated the contri-
bution of Y chromosome expression in the different human
pluripotent cell lines. By analyzing only Y-specific probe sets,
we detected that male human pluripotent stem cells expressed
16 out of the 19 X-degenerate and X-transposed genes (Fig-
ure S1B). Next, we analyzed the Y-specific genes, which are
thought to have testis-specific expression. As expected, most
of the Y-specific genes were not expressed in male ESCs, but
were expressed in the spermatogonia samples (Figure 1A). How-
ever, to our surprise, the male pluripotent stem cells expressed
the male-determining gene SRY (Figures 1A, 1B, and S1C). To
specifically show that SRY expression is related to the pluripo-
tent state, we sorted ESCs via fluorescence-activated cell sort-
ing (FACS) according to TRA-1-60 expression and tested the
highly purified population of pluripotent cells for SRY expression.
As shown in Figure 1C, SRY was highly expressed in TRA-1-60-
positive male cells together with OCT-4 expression, indicating
that SRY was mainly expressed in the pluripotent fraction of
male cells. Next, we examined whether reprogramming of so-
matic male cells to iPSCs would reactivate SRY expression. A
quantitative PCR (qPCR) analysis of reprogrammed iPSCs and
their parent cells confirmed that SRY was reactivated following
reprogramming of somatic cells (Figure 1D). Finally, we analyzed
the activation state of SRY by utilizing data available from the
NIH Roadmap Epigenomics Mapping Consortium (https://
commonfund.nih.gov/epigenomics) (Bernstein et al., 2010).
RNA sequencing (RNA-seq) data from H1 male ESCs showed
reads only from the minus strand (Figure S2A), whereas H1 cells
following trophoblast or mesenchymal differentiation showed no
reads in this region, similar to what was observed for the fully
differentiated somatic fibroblast samples. Concomitantly, chro-
matin immunoprecipitation sequencing (ChIP-seq) data for un-
differentiated H1 male ESCs showed higher levels of the active
markers H3K27ac, H3K9ac, H3K4me2, and H3K4me3, and
lower levels of the repressive markers H3K27me3 and
H3K4me1 as compared with their differentiated and somatic
counterparts (Figures S2A and S2B). To isolate the elements
on the Y chromosome that are needed for SRY activation in
the pluripotent state, we generated iPSC lines from genetically
female but phenotypically male sex-reversion (SR) patients924 Cell Reports 8, 923–932, August 21, 2014 ª2014 The Authors(XX+SRY-SR). In these patients, SRY is located on the X chromo-
some due to an X-Y translocation, resulting in males with two XX
chromosomes. Following reprogramming, the XX+SRY-SR iPSCs
expressed the pluripotent markersOCT-4,NANOG, and TRA1 1-
60 (Figures S3A–S3C), generated teratomas in NOD-SCID mice
that contained cells originating from all three germ layers (Fig-
ure S3D), and were of a normal karyotype except for a small
addition to the X chromosome (Figure S3E). As can be seen in
Figure 2A, the XX+SRY-SR iPSCs reactivated SRY expression
similarly to the male iPSCs, confirming that such reactivation is
independent of factors expressed from the Y chromosome. We
further confirmed SRY activation by transfecting cells with a
YFP reporter gene fused to a 5 Kb region of the human SRY pro-
moter (PSRY-YFP) (Boyer et al., 2006). In addition to the ex-
pected expression of the PSRY-YFP construct in male and
XX+SRY-SR cells, we found that female ESCs could also utilize
the SRY promoter and drive YFP expression at similar levels (Fig-
ures 2B and 2C). In contrast, male fibroblasts transfected with
the same reporter gene showed only negligible YFP expression
(Figures 2B and 2C). Similar experiments using shorter segments
of the SRY promoter showed that the proximal 460 bp of PSRY
are sufficient to drive reporter expression (Figure 2D). A bio-
informatic analysis of this region using the GenericModel Organ-
ism Database (GMOD) software (McKay et al., 2010) revealed
that it contains a putative OCT4-SOX2-binding site. To further
our understanding of SRY activation in pluripotent cells, we per-
formed small interfering RNA (siRNA) experiments in which the
levels of the pluripotent genesOCT-4 andNANOGwere reduced
in male ESCs. Reducing either NANOG or OCT-4 by siRNA re-
sulted in reduced levels of SRY (Figure 2E). The reduction in
NANOG or OCT-4 did not affect the levels of other pluripotent
genes (LIN28 and REX1). These data suggest that the SRY pro-
moter is active in pluripotent cells and that SRY is regulated by a
pluripotent gene.
To better understand the dynamics of SRY expression, we
differentiated ESCs into embryoid bodies (EBs) and monitored
SRY expression. Differentiation resulted in a rapid decline of
SRY expression levels, in accordance with the decrease in
NANOG levels (Figure 2F). Additional experiments using PSRY-
YFP-transfected female ESCs confirmed that YFP levels
decreased by day 7 of EB differentiation (Figure S3G). Hence,
our results indicate that SRY expression is inherent to the plurip-
otent state and that its activation is specific, as the 460 bp up-
stream region is sufficient to drive expression even in female cells.
Sex-Specific Autosomal Gene Expression
Next, we set out to identify whether Y-linked gene expression
might result in differential autosomal gene expression. A prin-
cipal component analysis based on the expression of only the
autosomal genes showed that sex divides the pluripotent cells
into separate groups (Figure 3A). Further analysis revealed 227
differentially expressed genes (fold change > 1.5, Bonferroni
p < 0.05, represented by 368 probe sets), with 32% of the genes
showing a >2-fold difference (Figures 3B and 3C; Table S2). Of
these, 142 genes had higher expression in male cells and 85
had higher expression in female cells. Hierarchical clustering
based on these genes could distinguish between male and fe-
male pluripotent cells, acting as a ‘‘sex fingerprint’’ (Figure 3C).
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Figure 1. Y-Specific Gene Expression in Pluripotent Stem Cells
(A) Expression levels of Y-specific genes from the microarray data set. Green bars, spermatogonia; brown bars, ESCs; blue bars, iPSCs. Empty bars indicate
absent call values.
(B) qPCR of SRY in ESC lines using the TaqMan probe.
(C) TRA-1-60-positive cells express SRY at higher levels. ESCs were sorted on the basis of TRA-1-60 expression. SRY expression was determined for each pop-
ulation using the TaqMan probe (blue bar). The pluripotency of TRA-1-60-positive cells was confirmed by assessingOCT-4 expression levels (green bar) (*p < 0.05).
(D) qPCR of SRY in iPSC lines using the TaqMan probe.
All error bars represent ± SE. See also Figures S1 and S2.
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Figure 2. SRY Promoter Activity in Pluripotent Stem Cells
(A) SRY expression following reprogramming of XX+SRY-SR iPSCs was determined by qPCR.
(B) Fluorescent images show that YFP expression is driven from the SRY 5 Kb promoter region in pluripotent cells, but not in male fibroblasts. Cells were
transiently transfected with YFP reporter under 5 Kb of SRY regulatory elements (PSRY-YFP) and a constitutive CFP reporter. Cells were fixed and stained with
DAPI and OCT-4 to confirm pluripotency. Bar, 20 mm.
(C) Quantification of YFP expression by high-content screening analysis using ScanR software. CFP expression was used to normalize for transfection efficiency.
(D) Mapping the minimal activation region of SRY promoter in ESCs. Serial deletions of PSRY were created and the expression of YFP was measured following
transfection to ESCs. Values represent the relative fold in comparison to the 5 Kb region. CFP expression was used to normalize for transfection efficiency.
(E) ReducingOCT-4 orNANOG by siRNA results in decreased SRY expression in male ESCs. Note that the pluripotent genes LIN28 andREX1 remain unaffected.
HUES11 male ESCs were transfected with either OCT-4 or NANOG siRNA, and RNA was extracted at 60 hr posttransfection and converted to cDNA for qPCR
analysis (*p < 0.05).
(F) qPCR of SRY in ESCs following spontaneous differentiation into EBs.
All error bars represent ± SE. See also Figure S3.No significantly differentially expressed genes were discovered
when the same data set was randomly segregated into two
groups or classified according to cell type (ESC or iPSC). To bet-
ter understand the biological processes in pluripotent cells that
may differ between the sexes, we performed a functional anno-
tation analysis (Huang et al., 2009a, 2009b) on the differentially
expressed genes. This analysis identified a marked enrichment
(fold = 4.1, p < 0.05) for genes involved in chromatin modeling.
Included in this group is the macroH2A2 gene (H2AFY2, F/M =
1.82389, Bonferroni = 0.006), which is enriched on inactive X
chromosomes (Chadwick and Willard, 2001) and is expected
to be highly expressed in females. Of special interest was the
identification of an 8.3-fold enrichment for gene groups involved926 Cell Reports 8, 923–932, August 21, 2014 ª2014 The Authorsin cholesterol and steroid metabolism (p < 0.05; Table S3). In
addition, we found that genes involved in regulating the differen-
tiation of known sex-dimorphic traits, such as inhibitor of DNA
binding 2 (ID2) and the CCCTC-binding factor-like protein
(CTCFL/BORIS), were differentially expressed even at this early
stage (Figures S3H and S3I). To examine whether SRY expres-
sion could contribute to the differential autosomal gene expres-
sion, we searched the promoters of the ‘‘sex signature’’ genes
for SRY-binding sequences. Promoter analysis (Ulitsky et al.,
2010) on the differentially expressed genes predicted SRY-bind-
ing sites in 85 genes (p = 0.021). Thus, SRY expression may
influence autosomal gene expression and thereby contribute to
the differences seen between males and females.
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Figure 3. Differential Autosomal Gene Expression between Male and Female Pluripotent Stem Cells
(A) Principal component analysis based on 22,419 probe sets shows independent clustering of each sex-related sample.
(B) Scatterplot depicting the expression levels of all probe sets used in this study. Blue, nonsignificant probes; black, significant probes (Bonferroni < 0.05) with
expression difference > 1.5.
(C) Heatmap of differentially expressed genes in male and female human pluripotent stem cells. Note that hierarchical clustering based on these genes separates
the samples according to sex.
(D) qPCR of SRY transgene stable expression in H9 and I3 female ESC lines using Syber green probes (*p < 0.05).
(E) SRY expression induces SOX9 expression in female ESCs, confirmed by qPCR analysis (*p < 0.05).
All error bars represent ± SE.Steroid Metabolism-Related Genes in Male and
Female Cells
Following our initial finding regarding the functional enrichment
of steroid-related genes among the sex-differential genes (Ta-
ble S3), we detected that female pluripotent cells express
higher levels of the steroid metabolism genes DHCR24,
OSBPL9, PCSK9, SRD5A3, and HSD17B12, whereas males
express ABCA1, HDLBP, PBX1, and CPT1C at higher levels
(Figure 4A). A closer examination of the data revealed addi-
tional statistically significant (Bonferroni < 0.05) steroid-related
genes, albeit at a lower fold change (Figure 4B). These includedthe cholesterol-processing genes SQLE (F/M = 1.31) and
CYP51A1 (F/M = 1.24). To verify the differential expression of
steroid metabolism genes, we tested selected genes in the
pathway by qPCR. As expected, qPCR confirmed that
ABCA1 expression was higher in male cells compared with fe-
male cells, and HSD17B12 expression was higher in female
cells (Figures 4C and 4D). To test SRY’s effect on autosomal
genes, we stably transfected female ESCs with SRY (XX+SRY-
ES). High levels of SRY were found in the manipulated cells
(Figure 3D) and, as expected, SRY overexpression increased
the expression of its known target, SOX9, in female ESCsCell Reports 8, 923–932, August 21, 2014 ª2014 The Authors 927
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Figure 4. SRY Expression Influences Steroid Metabolism in Female Pluripotent Stem Cells
The differential expression of steroid metabolism pathway genes is influenced by SRY expression, resulting in an altered response to estrogen precursor
estrone (E1).
(A) Table of steroid metabolism pathway genes differentially expressed in male and female cell lines.
(legend continued on next page)
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(Figure 3E). SRY transfection into the female ESCs resulted in
increased expression of ABCA1 and decreased expression of
HSD17B12 (Figures 4C and 4D). Thus, these genes are affected
by SRY, supporting the discovery of a putative SRY-binding
site in the ABCA1 promoter. HSD17B12 converts the inactive
estrogen precursor estrone (E1) into the active 17b-estradiol
(E2, estrogen; Figure 4B). As estrogen (E2) induces cell growth
in both pluripotent and somatic cells (Wong et al., 2012), we
tested whether administration of estrone (E1) would have a
differential effect on male and female cells. Exposing male, fe-
male, and XX+SRY ESCs to 100 nM E1 for 48 hr resulted in pro-
liferation of the female ESCs, whereas the growth of male and
XX+SRY ESCs was unaffected (Figure 4E), as detected by cell-
viability analysis. In contrast, administration of 100 nM E2 re-
sulted in proliferation of both male and female cells, confirming
the female-specific E2 synthesis capabilities (Figure 4E). To
better understand the mechanism by which estrogen increased
cell proliferation in the pluripotent cells, we exposed the cells to
E1, E2, and vehicle, and tested their effects on cell cycle and
apoptosis. Female cells showed no difference in the proportion
of cells in G2/M following either E1 or E2 exposure (Figure 4F).
In contrast, male and XX+SRY ESCs showed a lower fraction of
cells in G2/M following E1 exposure as compared with E2
exposure (Figure 4F). Next, we used Annexin V staining to
examine the effects of estrogen derivatives on apoptosis. As
shown in Figure 4G, we detected no significant differences,
regardless of sex or treatment, in the proportion of cells that
underwent apoptosis.
To better understand the consequences of the differential ste-
roid metabolism on early development, we differentiated male
and female ESCs by EB formation for 11 days in the presence
of E1 and compared their global gene-expression patterns. A
K-means analysis identified 584 genes with fold change > 2
that responded to E1 only in female cells. A functional analysis
of these genes detected an enrichment of the neuronal differen-
tiation pathway (p = 2.8 3 107; Figure 4H; Table S4). Taken
together, these results suggest that SRY expression drives dif-
ferential gene expression, leading to differential sex hormone
metabolism that affects growth by inducing cells to entermitosis,
and that the difference in E1 metabolism can influence early
development.(B) Suggested model for steroid synthesis in ESCs. Increased expression of SQL
The cholesterol is then retained in the cell due to reduced ABCA1 and HDLBP e
(C) Expression of the cholesterol efflux transporter ABCA1 is induced by SRY ex
(D) HSD17B12 is inhibited by SRY expression in female ESCs (*p < 0.05).
(E) Differential response to E1 bymale and female ESCs. ESCswere serum starved
Cell numbers were quantified by methylene-blue assay and normalized to growth
number following E1 exposure, whereas the growth of male ESCs (I6 and HUE
H9+SRY) resulted in growth inhibition similar to that observed for male cells.
(F) Ratio of cell-cycle response to E1 and E2 exposure. ESCs were subjected to E1
cells were fixed and the cell cycle was determined by propidium iodide staining
exposure, whereas females showed no difference between E1 and E2 exposure
(G) Apoptosis rate was determined using Annexin-V FITC following steroid exposu
and females or the conditions used.
(H) Expression array data from male and female samples following 48 hr and 11 d
analysis in order to identify genes that were upregulated in females only. Function
performed in the DAVID Functional Annotation Tool (Huang et al., 2009a, 2009b)
All error bars represent ± SE.DISCUSSION
In the current study, we set out to identify differences in gene
expression driven by Y chromosome content. Surprisingly our
analysis revealed that male pluripotent stem cells express the
sex-determining gene SRY (Figures 1A–1D). SRY is located in
the X degenerate region of the Y chromosome and bears a close
resemblance to the X-linked SOX3 gene (Sinclair et al., 1990).
However, according to both the microarray data and qPCR ex-
periments, SOX3 expression was not upregulated in females,
suggesting that it does not compensate for SRY expression
(Figures S1D and S3F). This observation is in agreement with
previous studies showing that SOX3 mutations do not result in
disorder of sexual development (Lim et al., 2000) and that at
normal expression levels, SOX3 is unable to replace SRY in
driving SOX9 expression (Weiss et al., 2003). Thus, in spite of
its location, SRY is a Y-specific gene with unique male expres-
sion and function. In adult males, SRY is expressed in germ cells
(Hanley et al., 2000), which may be considered as specialized
pluripotent cells. Indeed, germ cells express some of the plurip-
otent genes seen in ESCs, such as OCT-4 and SOX2 (Izadyar
et al., 2011). Therefore, the expression of SRY in male ESCs
prompted us to investigate the connection between SRY and
the pluripotent state. SRY expression is induced by reprogram-
ming of male fibroblasts to iPSCs (Figure 1D). Furthermore,
reducing the expression levels of both OCT-4 and NANOG by
siRNA transfection to male ESCs resulted in reduced SRY
expression (Figure 2E). Interestingly, SRY activation was inde-
pendent of any Y chromosome factors, as reprogramming of fi-
broblasts from SR patients (XX+SRY-SR) also resulted in SRY
activation (Figure 2A). These findings are supported by our dis-
covery that a small region of the SRY promoter was actively
recognized in both male and female ESCs, confirming that the
machinery needed for SRY activation is present in all pluripotent
cells and that no other Y-linked gene is needed for such activa-
tion (Figures 2A–2D). It should be noted that both our results and
a previous analysis of the SRY promoter region revealed multiple
putative OCT-4 recognition sites (Kang et al., 2009), even in
the proximal 460 bp region that was sufficient for driving YFP re-
porter expression. Our data regarding the minimal region of SRY
promoter needed for activation are further supported by recentE, CYP51A1, and DHCR24 results in elevated cholesterol synthesis in females.
xpression, resulting in higher levels of estrogen (E2) produced by HSD17B12.
pression in female ESCs (*p < 0.05).
for 24 hr in phenol-freemedium followed by 48 hr exposure to 100 nME1 or E2.
in starvation medium only. Female ESCs (I3 and H9) show an increase in cell
S11) is retarded. Notice that expression of SRY in female cells (I3+SRY and
, E2, or vehicle as described above. Twenty-four hours following exposure, the
. XY and XX+SRY ESCs had a reduced fraction of cells in G2/M following E1
.
re as described above. No significant difference was observed betweenmales
ays of differentiation in the presence of 100 nM E1 were subjected to K-means
al annotation clustering of female upregulated genes (584 genes, fold > 2) was
.
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experiments showing that a small region (1.4 Kb) of the human
SRY promoter was able to drive reporter expression in mouse
ESCs (Silversides et al., 2012). Furthermore, a bioinformatic
analysis of this region revealed multiple HOXF motifs that are
recognized by NANOG (Ross et al., 2008), which was further
confirmed by the identification of SRY as a NANOG target in
ChIP experiments (Lister et al., 2009). In addition to SRY activa-
tion in pluripotent cells, monitoring SRY during EB differentiation
of male ESCs revealed a sharp decline in SRY expression (by
day 7) together with the decline in expression of pluripotent-spe-
cific genes (Figure 2F). Taken together, our results show that
SRY activation is an intrinsic part of the pluripotent state. Based
on this notion, it is tempting to consider that SRY activation in
germ cells is achieved by a pluripotent network similar to that
observed in ESCs.
Using our large data set of male and X-inactivated pluripotent
samples, we were able to detect a difference in autosomal gene
expression between male and female pluripotent stem cells.
We found 227 genes differentially expressed between male
and female pluripotent cells, 85 of which are predicted to contain
SRY-binding sites (Figures 3B and 3C; Table S2). Thus, SRY is
only partly responsible for the differential gene expression seen
between male and female cells. This result is in accord with a
previous study in which sex chromosome complement and
SRY were shown to have separate effects on global gene
expression in mice (Wijchers et al., 2010).
Surprisingly, a functional analysis of the sex-differential genes
revealed enrichment for genes involved in steroid metabolism.
These genes may be separated into three groups: (1) genes
involved in cholesterol synthesis (DHCR24, SQLE, and
CYP51A1), (2) genes involved in cholesterol or steroid homeo-
stasis (OSBPL9, PCSK9, ABCA1, HDLBP, PBX1, and CPT1C),
and (3) genes involved in the generation of sex steroids
(SRD5A3 and HSD17B12). Female pluripotent stem cells ex-
press higher levels of cholesterol and estrogen synthesis genes
(DHCR24, SQLE, CYP51A1, and HSD17B12), whereas male
cells express higher levels of the cholesterol efflux transporters
ABCA1 and HDLBP. Indeed, addition of E1 to ESCs resulted in
an increase of female cell numbers, whereas male growth was
unaffected. However, exposing cells to active E2 resulted in
cell proliferation regardless of sex (Figure 4E). This increase in
cell number following E1 exposure is probably due to increased
proliferation of female cells, as E1 was able to increase the frac-
tion of female cells in G2/M. Based on the differential gene
expression of the steroidmetabolism-related genes, we propose
a model in which female pluripotent stem cells have increased
cholesterol uptake that is directed toward estrogen production,
whereas male pluripotent stem cells have reduced cholesterol
uptake and synthesize less estrogen (Figure 4B). During fetal
life, the placenta plays a crucial role in steroid hormone produc-
tion. However, this role is only assumed later in pregnancy,
following degradation of the corpus luteum around the fifth to
eighth week (Scott et al., 1991). Local production of sex steroids
is known to play an important role in various tissues (Kamat et al.,
2002). Our results suggest that local sex steroid production may
also be important during the initial pluripotent stages of deve-
lopment. Indeed, exposing male and female ESCs to E1 during
differentiation resulted in differential expression of neuronal930 Cell Reports 8, 923–932, August 21, 2014 ª2014 The Authorsdevelopment genes (Figure 4H; Table S4), which may provide
initial evidence for dimorphic traits seen in brain development.
The ability of forced SRY expression in female ESCs to increase
ABCA1 expression together with a reduction of HSD17B12
expression, as well as the mimicking of the male response to
E1 (Figures 4C and 4D), indicates that SRY plays an important
role in the sex-hormone response. Further analyses of hormone
levels in ESCs and experiments to confirm SRY targets are
needed to better elucidate the contribution of each system to
differential gene expression.
Taken together, our results show that during early human em-
bryonic development, the Y chromosome and specifically the
male-specific gene SRY may contribute to sex-dimorphic traits.
This effect is achieved by both direct activation of key autosomal
genes and the autocrine or paracrine effects of sex steroids in
ESCs. Thus, during early development, genetic content is inti-
mately connected to hormone production, and both influence
differential gene expression. Clarifying the specific effect of
Y chromosome genes and sex steroids in ESCs will allow us to
better understand the basic role of sex chromosomes in stem
cell biology and early development. Specifically, future efforts
to elucidate the targets and mode of activation of SRY, as well
as the role of self-produced sex hormones in ESCs, will be of
great importance.
EXPERIMENTAL PROCEDURES
Cell Culture
Human ESCs and iPSCs were maintained on a mitomycin-arrested mouse
embryonic fibroblast (MEF) feeder layer as previously described (Bar-Nur
et al., 2011). The cell lines used in this study are listed in Table S5. iPSCs
were generated as previously described (Bar-Nur et al., 2011) from
GM02670 cells obtained from the Coriell Institute Cell Repository.
Plasmids and Constructs
The SRY gene was PCR amplified from genomic DNA of BJ iPS#28 cells and
cloned into pEGFP (Clontech) as described in Supplemental Experimental
Procedures. The 5 Kb region of human SRY promoter fused to YFP (PSRY-
5Kb-YFP) was a kind gift from Dr. David W. Silversides.
Transfection and Immunostaining
Transient DNA transfection was performed using TransIT-LT1 (Invitrogen) ac-
cording to the manufacturer’s instructions. For stable expression of SRY or
PSRY constructs, an additional selection stage using G418 was performed
following transfer of ESCs to MEF-plated wells. For siRNA transfection, 10 ml
of 20 mM ON-Target-Plus smart pool siRNA (Thermo Scientific) was trans-
fected into cells using Lipofectamine2000 reagent (Life Technologies) accord-
ing to the manufacturer’s instructions.
Fluorescence Microscopy and Image Analysis
Image analysis and quantification were performed using the ScanR analysis
software. Teratoma section images were taken on an Olympus IX70 mounted
with a DP70 camera.
RNA Extraction and qPCR Analysis
Total RNA was extracted using the RNAeasy Mini Kit (QIAGEN) and treated
with DNAase according to the manufacturer’s protocol. One microgram of to-
tal RNA was used for reverse transcription using ImProM-II (Promega) with
random hexamer primers. qPCR was performed on a 7300 Real-Time PCR
system (Applied Biosystems) using either Taqman Universal PCRmix or Syber
Green mix (Applied Biosystems) with an annealing temperature of 60C for 40
cycles. The primers used are listed in Table S6. All results were normalized to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
DNA Microarray Analysis
Expression array data were downloaded from the GEO database and normal-
ized together using the MASS5 method in the Affymetrix Expression Console.
For detection of the E1 effect, cells were exposed to E1 (for 0 or 48 h, or for
11 days as EBs) as described below, followed by RNA extraction and global
gene expression was determined using the Affymetrix Gene ST 1.0 platform
according to the manufacturer’s protocol. The samples used in this study
are detailed in Tables S1 and S5.
Estrone Response Assay
After 24 hr starvation, the medium was replaced with starvation medium
containing either 100 nM estrone (Sigma-Aldrich), 100 nM 17-b-estradiol
(Sigma-Aldrich), or ethanol as control and incubated for 48 hr. The relative
cell numbers were determined by methylene blue staining and normalized
relative to the ethanol control.
FACS Analysis
For enrichment of pluripotent cells, male ESCs grown on MEFs were dissoci-
ated using TrypLE Select (GIBCO). The cells were washed with FACS medium
(PBS containing 10% fetal calf serum) and then incubated with phycoerythrin-
conjugated TRA-1-60 antibody (Santa Cruz) for 60 min (1:40; BD Pharmingen)
on ice. Excess antibody was washed with FACS medium and the cells were
sorted into cold tubes using a BD FACS Aria III.
Cell-Cycle Analysis
Cells were prepared in six-well plates as described above (‘‘Estrone Response
Assay’’), with each well receiving a different treatment. Following propidium
iodide (Sigma-Aldrich) staining, the cells were analyzed using a BD FACS
Aria III.
Apoptosis Analysis
Cells were prepared in six-well plates as described above (‘‘Estrone Response
Assay’’). Following the exposure period, the cells were subjected to Annexin
V-FITC staining using the MEBCYTO Apoptosis Kit (MBL International)
according to the manufacturer’s instructions. The fraction of FITC-positive
cells was determined by using a BD FACS Aria III.
Epigenetic Data Analysis
RNA-seq and ChIP-seq data were downloaded from the NIH Roadmap Epige-
nomics Mapping Consortium (https://commonfund.nih.gov/epigenomics)
(Bernstein et al., 2010). Reads were summed for 1,000 bp surrounding the
SRY gene (hg19 Y:2653896-2656792), giving a total of 2,896 bp, and divided
by length to give values of reads/Kb (RPK).
ACCESSION NUMBERS
The NCBI Gene Expression Omnibus accession number for the microarray
data reported in this paper is GSE58591.
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